Forget your password?


What is RenValue?

Qualified patients with either commercial prescription insurance or no insurance can utilize the RenValue coupon program to help cover the out-of-pocket cost of Renvela® (sevelamer carbonate).

Renvalue Card

Who is eligible?

  • Patients with either commercial prescription insurance or no prescription insurance.

Who is not eligible?

  • Patients participating in Medicaid, Medicare Part D, Veteran Affairs, Indian Health Service, or other federal or state programs are not eligible for this benefit.

What are the benefits?

For patients with commercial insurance:
  • Patients pay $5 for each of 12 refills for claims up to $300.

Renvalue Card

For patients with no insurance:
  • Patients save up to $300 off out-of-pocket costs for each of 12 fills.

Renvalue Card

Visit the RenValue website to learn more.

Where do I get the RenValue card?

Visit the RenValue website to print your own or call Renassist® to have a card mailed to you.

Visit our website
Visit our website
Click here for Ferrlecit Important Safety Information and Full Prescribing Information

Visit our website
Click here for Hectorol Important Safety Information and Full Prescribing Information

Indication for Renvela and Renagel
Renvela® (sevelamer carbonate) and Renagel® (sevelamer hydrochloride) are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.

Important Safety Information for Renvela and Renagel
  • Sevelamer is contraindicated in patients with bowel obstruction.
  • Caution should be exercised in patients with dysphagia, swallowing disorders, and severe gastrointestinal (GI) motility disorders, including severe constipation or major GI tract surgery.
  • Common adverse events reported with sevelamer include vomiting, nausea, diarrhea, dyspepsia, abdominal pain, flatulence, and constipation. Other events reported include pruritus, rash, fecal impaction and, less commonly, ileus, bowel obstruction, and bowel perforation.
  • Uncommon cases of difficulty swallowing the Renagel (sevelamer hydrochloride) or Renvela® (sevelamer carbonate) tablet have been reported. Caution should be exercised in these patients and consideration given to using Renvela® (sevelamer carbonate) suspension in patients with a history of difficulty swallowing.
  • Drug-drug interactions may occur with some medications and should be taken into consideration when instructing patients how to take sevelamer.
  • Serum bicarbonate and chloride levels should be monitored.
  • Follow patients for reduced vitamins D, E, and K (coagulation parameters) and folic acid levels.
  • Patients should be informed to take sevelamer with meals and to adhere to their prescribed diets.

Please click here for full Prescribing Information for Renvela (PDF) or full Prescribing Information for Renagel (PDF).

    Terms and conditions  |  Privacy policy  |  Prescribing Information for Renvela®  |  Prescribing Information for Renagel®  |  Contact Renassist  |  Resources